ARQT
Arcutis Biotherapeutics Inc
26.90$
+2.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -6,991.7% | -414.5% | -57.1% | -1.5% | |
| – | – | – | – | – | 25.3% | 2.6% | 1.3% | 1.2% | |
| – | – | – | – | – | 886.7% | 65.1% | 21.2% | 10.7% | |
| – | – | – | – | – | 1,708.7% | – | – | – | |
| – | – | – | – | – | -276.0% | -39.4% | -7.7% | -9.3% | |
| – | – | – | – | – | 631.7% | 0.7% | 0.1% | 0.2% | |
| – | – | – | – | – | -2,365.7% | 302.4% | 14.7% | -8.0% | |
| – | – | – | – | – | 3,331.9% | – | – | – | |
| – | – | – | – | – | 338.3% | – | – | – | |
| – | – | – | – | – | 3,391.2% | 0.0% | -50.9% | 0.0% | |
| – | – | – | – | – | 8,187.7% | 170.0% | 33.7% | 1.9% | |
| – | – | – | – | – | -1,169.7% | 57.8% | -8.8% | -7.6% | |
| – | – | – | – | – | -7,623.4% | -415.2% | -57.1% | -1.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.